Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
Agree Realty Corporation Reports Third Quarter 2025 Results
04:05pm, Tuesday, 21'st Oct 2025
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced results for the quarter ended September 30, 2025. All per share amounts included herein are
What Analyst Projections for Key Metrics Reveal About Agree Realty (ADC) Q3 Earnings
10:16am, Monday, 20'th Oct 2025
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Agree Realty (ADC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the
Agree Realty: Increased Dividend, Earnings On Track To Exceed Expectations
08:59am, Friday, 17'th Oct 2025
Agree Realty Corporation is rated a Buy for investors seeking income and capital appreciation from a high-quality, recession-resistant REIT. ADC boasts a 4.2% forward yield, consistent dividend growth
Agree Realty: Quality Becomes More Relevant
08:51am, Thursday, 16'th Oct 2025
ADC stands out for its superior credit quality, conservative balance sheet, and high proportion of investment-grade tenants in the net lease sector. Despite sector turmoil and rising concerns over cre
Most investors have probably never heard of Agree Realty (ADC 0.77%). However, you might have spent some time in one of the real estate investment trust's (REIT) properties before.
Agree Realty Declares Increased Monthly Common Dividend
04:05pm, Tuesday, 14'th Oct 2025
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash div
ADC Therapeutics Announces $60 Million Private Placement
07:30am, Monday, 13'th Oct 2025
LAUSANNE, Switzerland , Oct. 13, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) will present new clinical research across its DXd antibody drug conjugate (ADC) portfolio with four late-breaking presentations
REITs On Clearance In A Rate Cut World: Here's 2 With Prices That Are Right
11:09am, Saturday, 11'th Oct 2025
Essential Properties Realty Trust and NNN REIT present attractive long-term buying opportunities due to strong fundamentals and resilient income profiles. EPRT boasts high occupancy (99.6%), low lever
BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced
2 Potentially Overhyped REITs With Red Flags
08:15am, Thursday, 09'th Oct 2025
Not all REITs are worth buying. Many property sectors are facing growing headwinds. I highlight 2 popular REITs to avoid.
Lisata Therapeutics and Catalent Announce Global Antibody-Drug Conjugate (ADC) License Agreement
08:30am, Wednesday, 08'th Oct 2025
Catalent gains global rights to evaluate certepetide and its analogs for use as SMARTag® payloads across multiple ADCs designed to address difficult-to-treat diseases
Omni Design Technologies Tapes Out Ultra-High-Speed 64GSPS ADC on TSMC N3 process
09:00am, Tuesday, 07'th Oct 2025
MILPITAS, Calif.--(BUSINESS WIRE)-- #ADC--Omni Design Technologies, a leading provider of high-performance, low-power Wideband Signal Processing™ solutions, today announced the tape out of its new O
5 Dividend Stocks I Can't Wait To Buy In October (Plus Macro Update)
08:15am, Saturday, 04'th Oct 2025
The US stock market is highly concentrated, with technology and tech-related stocks now comprising about 55% of total market cap. This concentration justifies higher valuation multiples for SPY, as te
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:05pm, Wednesday, 01'st Oct 2025
LAUSANNE, Switzerland , Oct. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced th
